To estimate the risk of ventricular arrhythmia (VA) or sudden death following SSRI initiation among users of antipsychotics, specifically focusing on the interaction between these medications.
Key Findings:
Antipsychotics are consistently associated with higher rates of sudden death compared to nonuse.
Evidence for SSRIs shows mixed results, with some studies indicating a modest increase in out-of-hospital cardiac arrest, particularly with citalopram, while others show no increased risk.
Concurrent use of antipsychotics and SSRIs is common in clinical practice despite potential risks.
Interpretation:
The clinical impact of combining antipsychotics and SSRIs on VA and sudden death necessitates further research on their combined effects to clarify potential risks.
Limitations:
Prior studies evaluated antipsychotics and SSRIs separately, limiting understanding of their combined arrhythmic outcomes.
Variability in practice patterns and medication selection across health care systems may affect generalizability.
Potential confounding factors may not have been adequately controlled for in the analysis.
Conclusion:
Further investigation is needed to clarify the arrhythmic risks associated with the combined use of antipsychotics and SSRIs, emphasizing the clinical implications of these findings.
